Page last updated: 2024-10-28

hydrochlorothiazide and 2019 Novel Coronavirus Disease

hydrochlorothiazide has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Prtajin, M1
Ljubojević Hadžavdić, S1
Bossoni, S1
Chiesa, L1
Giustina, A1

Other Studies

2 other studies available for hydrochlorothiazide and 2019 Novel Coronavirus Disease

ArticleYear
Pityriasis Rosea after COVID-19 Infection.
    Acta dermatovenerologica Croatica : ADC, 2022, Volume: 30, Issue:4

    Topics: COVID-19; COVID-19 Vaccines; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Herpesvirus 6, Hum

2022
Severe hypocalcemia in a thyroidectomized woman with Covid-19 infection.
    Endocrine, 2020, Volume: 68, Issue:2

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Calcium; Calcium Gluconate; Coronav

2020